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Vomocytosis: Too Much Booze, Base, or Calcium?
Melissa Cruz-Acuña,a Noah Pacifici,a Jamal S. Lewisa
aDepartment of Biomedical Engineering, University of California, Davis, Davis, California, USA
ABSTRACT Macrophages are well known for their phagocytic activity and their role
in innate immune responses. Macrophages eat non-self particles, via a variety of
mechanisms, and typically break down internalized cargo into small macromolecules.
However, some pathogenic agents have the ability to evade this endosomal degra-
dation through a nonlytic exocytosis process termed vomocytosis. This phenomenon
has been most often studied for Cryptococcus neoformans, a yeast that causes roughly
180,000 deaths per year, primarily in immunocompromised (e.g., human immunodefi-
ciency virus [HIV]) patients. Existing dogma purports that vomocytosis involves distinc-
tive cellular pathways and intracellular physicochemical cues in the host cell during pha-
gosomal maturation. Moreover, it has been observed that the immunological state of
the individual and macrophage phenotype affect vomocytosis outcomes. Here we com-
pile the current knowledge on the factors (with respect to the phagocytic cell) that pro-
mote vomocytosis of C. neoformans from macrophages.
KEYWORDS vomocytosis, macrophage, pH, phagosome, nonlytic exocytosis,
Cryptococcus neoformans
INTRODUCTION: WHAT GOES IN MUST COME OUT?
Phagocytosis by innate immune cells is important for cell-to-cell communication,metabolism, homeostasis, and organism survival (1–4). Macrophages are critical
players in the innate immune host defense system that recognize, internalize, and
neutralize foreign bodies (5). These specialized cells use a variety of mechanisms, which
are often concurrent and intertwined, to internalize particulate matter. Some of the
best-characterized uptake pathways in macrophages include (i) clathrin-mediated en-
docytosis, (ii) caveolae/raft-dependent endocytosis, (iii) macropinocytosis, (iv) micropi-
nocytosis, and (v) phagocytosis (Fig. 1A). The specific entry process depends on both
the physicochemical and biological properties of the particulate (6–9). Accordingly, the
intracellular fate of internalized cargo is influenced by the type of internalization
executed and nature of the internalized particulate (6, 8–10).
In the case of a fungal infection, macrophages are among the early immune cell
responders that typically internalize and clear fungal cells. This clearance involves the
accumulation of these phagocytes at the site of infection, recognition of cell surface,
fungus-specific characteristics, internalization, and degradation in an acerbic vacuole,
called the phagolysosome (6, 11). However, some fungi, such as Cryptococcus neofor-
mans, are capable of not only skirting innate immune actions but also escaping from
the grasp of these phagocytic cells after capture.
C. neoformans is a globally distributed and free-living basidiomycete, mostly found
residing within the decaying wood within tree trunk hollows and avian excreta (12).
Therefore, this species’ survival does not depend on infection of animal hosts. However,
the ease of exposure to C. neoformans, presumably by inhalation of infectious particles,
resulted in an estimated 220,000 cryptococcal meningitis cases in people living with
HIV/AIDS in 2017 (13). This organism has developed phagocyte escape capabilities that
contribute to its virulence within immunocompromised hosts. Some theorize that C.
neoformans may have developed these defenses against phagocytes in response to
pressure from environmental amoebae (14). However, the amoeba Dictyostelium dis-
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coideum was shown to expel phagocytosed C. neoformans primarily via Wiskott-Aldrich
syndrome protein and Scar homolog (WASH)-mediated constitutive exocytosis—an
80-min-long process involving actin restructuring and membrane recycling pathways,
which is distinct from vomocytosis (15). When WASH-mediated exocytosis is blocked, a
secondary, vomocytosis-like route of escape appears, characterized as a stochastic,
nonlytic exocytosis process that takes place over several hours. C. neoformans can
evade amoebae using constitutive exocytosis alone; therefore, the existence of vomo-
cytosis as a secondary exit process seems evolutionarily redundant. The true evolu-
tionary driver for this phenomenon has yet to be discovered. Vomocytosis (often
referred to as nonlytic exocytosis) has also been observed in C. neoformans-infected
macrophages. After expulsion from innate immune cells, C. neoformans is carried in the
bloodstream and disseminated to the brain (16).
In this review, we highlight the biological, chemical, and physical changes within the
phagocytic cell that are connected to vomocytosis. As a postscript, we discuss the
potential contributions of engineering to the study of this incredible behavior and
the prospective exploitation of this phenomenon for advances in biotechnology and
medicine.
ESCAPE FROM ALCATRAZ: BREAKOUT FROM MACROPHAGES
Most mammalian cells not only are capable of internalizing materials but also have
built-in mechanisms to deliver intracellular contents externally. Vacuolar contents can
exit the cell via exocytosis, a mechanism in which a vacuole fuses with the cell
membrane, releasing its contents outside the cell (17). Exocytosis is particularly relevant
in macrophages for a variety of intrinsic functions, such as phagocytosis and inflam-
mation, and also play a role in the diseased state (18–21). For instance, exocytosis of
intracellular compartments is required for phagosome formation in order to compen-
sate for the membrane utilized in phagocytosis, a dynamin-dependent process called
focal exocytosis (22). The secretion of the cytokine tumor necrosis factor (TNF) via
secretory carrier membrane protein 5 (SCAMP5) is another example of exocytosis (23).
Moreover, lysosomal enzymes delivered via exocytosis are also reported in the initial
degradation of dying or dead adipocytes in obesity and in tumorigenic cells clearance,
processes called exophagy and heterocytolysis, respectively (19, 20). Some internalized
pathogens, such as C. neoformans, Candida albicans, and Cryptococcus gattii, among
FIG 1 Foreign particulate entry and exit pathways into macrophages. Internalized cargo is typically directed to its degradation in a harsh,
degradative environment driven by acidity and lysosomal enzyme activity. C. neoformans, however, has the ability to manipulate the
progression of this process by exiting the cell via the nonlytic exocytosis mechanism, vomocytosis, which leaves the host cell intact, or
by lytic exocytosis, which results in the lysis of host cell. Depicted are the types of internalization mechanisms that have been observed
in macrophages. Their relative frequency of occurrence is not represented here or discussed in this article. This figure was created with
BioRender.
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others, have developed a mechanism to fuse their containment vacuoles with the cell
membrane, evading lysosomal degradation (24–26).
C. neoformans has developed unique lytic and nonlytic exocytosis mechanisms to
escape from phagolysosome degradation (Fig. 1B). Several studies have identified
virulence factors that promote escape, such as capsule shedding, laccase, and phos-
pholipase B1 (27–31). These observations suggest that these factors may contribute to
modifying host signaling events. Early studies on phagosomal escape demonstrated
that C. neoformans and the phagosome can be colocalized with phagosomal matura-
tion indicators such as major histocompatibility complex class II (MHC-II), CD63 (32, 33),
and LAMP-1 (26, 33), suggesting that the phagosome is at least partially matured.
However, more recent studies have identified phagosome maturation disruption at the
protein and physicochemical levels (34–36). Another mechanism of escape for C.
neoformans is cell-to-cell transfer or dragotcytosis. Together, these exit mechanisms,
which are further discussed below, aid in C. neoformans survival and dissemination in
human hosts.
Lytic exocytosis. The lysis of host cells is an important route of escape from the
intracellular environment for many pathogens (12, 37). However, pore-forming pro-
teins, which are commonly used by other pathogens to lyse host cells, have not been
identified in C. neoformans. Studies suggest that C. neoformans mechanically disrupts
host cells through proliferation within the phagosome and possibly via production of
large amounts of polysaccharide capsule (38, 39). Macrophages can undergo apoptosis
in response to intracellular cryptococcal signaling via the alternative NF-B pathway
(40). Further, macrophage lysis in response to intracellular C. neoformans has recently
been linked to phagosome membrane permeabilization and apoptosis (36).
Vomocytosis. Among the different exit mechanisms, vomocytosis (or nonlytic
exocytosis) by C. neoformans has been the best studied. In vomocytosis, a live fungal
cell is expelled from the phagosome while keeping the host cell intact (26, 41). Similar
phagocytic escape has been described for Candida albicans (25), Chlamydia spp. (42),
Orientia tsutsugamushi (43), and Cryptococcus gattii (44, 45). However, all of these
species have distinguishing features to their vomocytic mechanisms. In vomocytosis,
the phagosome fuses with the plasma membrane, releasing the cryptococcal cell (46).
In recent years, studies have demonstrated that this mechanism is highly regulated and
driven by C. neoformans, since the heat-killed pathogen is unable to promote vomo-
cytosis (26, 47).
Dragotcytosis/cell-to-cell transfer. Vomocytosis followed by phagocytosis by a
nearby cell has been characterized as a new C. neoformans phagosomal escape process
called dragotcytosis (48). The distinct feature of this mechanism is that there is
interaction between the donor and acceptor macrophages prior to and shortly after the
pathogen transfer event. Further molecular studies are needed to elucidate the cross
talk between macrophages and the internalized C. neoformans during dragotcytosis.
It is noteworthy that the escape of C. neoformans from phagocytic cells via the last
two described processes, vomocytosis and dragotcytosis, potentially explains how C.
neoformans may exploit phagocytes to penetrate the blood-brain barrier (BBB) in a
Trojan horse manner (49, 50). In previous studies, C. neoformans was detected inside
phagocytes on the outer side of a meningeal capillary, which suggests that C. neofor-
mans may have been transported within circulating phagocytes (51, 52). Moreover,
Santiago-Tirado and coworkers demonstrated the occurrence of this mechanism in vitro
(16). However, due to the difficulty of studying this mechanism in vivo, the extent to
which C. neoformansmay use the Trojan horse dissemination model to traverse into the
brain remains unknown.
Transcytosis. Transcytosis, possibly an indirect innate immune system evasion, is
the BBB cell penetration mechanism employed most by C. neoformans, which takes
advantage of cellular endocytosis (53, 54). Transcytosis of the BBB has been widely
demonstrated in vitro by showing the ability of C. neoformans to adhere to one or more
receptors on the endothelial cell barrier (55, 56). The process causes marked morpho-
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logical changes in the host cell, including membrane ruffling, irregular nuclear mor-
phology, and swelling of the mitochondria and the endoplasmic reticulum (ER) (57).
Studies suggest that transcytosis involves the migration of C. neoformans across the
BBB in a glycoprotein cluster-of-differentiation (CD44)dependent manner. C. neofor-
mans activates the ephrin A2 (EphA2) pathway via CD44, creating a permeable barrier
that promotes the migration of C. neoformans across the BBB (58). More molecular
events detailing the mechanisms underlying C. neoformans transcytosis remain to be
fully resolved.
Collectively, these mechanisms of escape aid in the survival and dissemination of C.
neoformans in the human body. However, the relationships between these processes
are currently unknown. Converse to phagocytosis, many questions remain over vomo-
cytosis, which was only identified in 2006 (26). Below, we discuss the characterized
features of macrophages that have been linked to vomocytosis of C. neoformans.
Vomocytosis involves cytoskeletal remodeling. The cytoskeleton has a promi-
nent role in phagocytosis, and therefore, its relevance in C. neoformans expulsion
should not be surprising. Reports have shown in detail how changes in the cytoskel-
eton promote pathogen survival and innate immune evasion (26, 46, 59). For instance,
Johnston and May found via three-dimensional confocal time-lapse imaging in vitro
(46) that there is a dynamic and repeated actin coat assembly around C. neoformans-
containing phagosomes. They also observed that vomocytosis occurred via the fusion
of phagosomal compartments and plasma membrane in J774 cells (a macrophage-like
cell line). This event was preceded by phagosomal permeabilization and followed by
actin coat assembly. When modulating actin polymerization they found that “flash”
(actin polymerization cycle) events are inversely related to nonlytic exocytosis, sug-
gesting its role in temporarily inhibiting vomocytosis.
PROTEIN NETWORKS INVOLVED IN VOMOCYTOSIS
Rab GTPase protein family.Members of the Rab GTPase protein family are integral
players in phagosomal maturation (60, 61). Rab5 is an early phagosome marker that
recruits for the progression of phagosomal maturation. Another early phagosome
marker is Rab11, which is relevant for phagosome fusion and fission with other
intracellular compartments by contributing to the dynein-dependent transport of
recycling endosomes. Rab9 and Rab7 are proteins associated with the late phagosomal
stage. The former is a marker of endoplasmic reticulum-derived membrane, and the
latter plays an essential role in the fusion of the late phagosome with a lysosome to
form the phagolysosome (61). Smith et al. demonstrated that live C. neoformans
promotes the rapid removal of the early phagosome markers Rab5 and Rab11 in J774
cells (Fig. 2) (34). This removal did not occur when infecting macrophages with the
heat-killed pathogen or inert beads. Additionally, Rab9 levels were significantly higher
on phagosomes containing live C. neoformans 2 h after phagocytosis than on phago-
somes containing heat-killed pathogen and latex beads. This report demonstrated how
C. neoformans affects phagosomal maturation at the protein level.
ERK5 signaling modulation. Another host protein that has been identified to play
a role in vomocytosis, as well as in phagocytosis, is extracellular-signal-regulated kinase
5 (ERK5). At the cellular level, the ERK5 pathway is required for colony-stimulating factor
1 (CSF-1)-induced proliferation and is linked to cell metabolism in macrophages
(62–65). Gilbert et al. demonstrated its critical role in suppressing the frequency of
vomocytic events (64). Pharmacological inhibition and genetic manipulation of ERK5
activity both significantly raise vomocytosis rates in human macrophages, whereas
stimulation of the ERK5 signaling pathway inhibits vomocytosis. Using a zebrafish
model of cryptococcal disease, this study showed that reducing ERK5 activity in vivo
stimulates vomocytosis and results in reduced dissemination of infection, likely due to
expulsion before macrophage migration (limiting the chance for Trojan horse trans-
port). Interestingly, modulation of the ERK5 signaling pathway did not induce expulsion
of heat-killed C. neoformans or inert beads, suggesting the active role of the pathogen
and a more complex molecular mechanism. Notably, ERK5 inhibition suppressed M2
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macrophage polarization in J774 cells and human monocyte-derived macrophages
(HMDMs) (64), suggesting an interesting dynamic between macrophage polarization
and vomocytosis.
Cathepsin activity. Cathepsins are hydrolytic enzymes that have optimal activity
under acidic conditions. They are important players in phagosomal maturation and are
also implicated in inflammasome activation. The NLRP3 inflammasome is a multimeric
protein complex important for infection eradication via the activation of interleukin 1
(IL-1) and IL-18, which has a central role in host defense (66). In a study by Lei et al.,
C. neoformans biofilm was found to stimulate NLRP3 inflammasome activation in
human monocytic THP-1 cells. Moreover, an increased rate of death was observed in C.
neoformans biofilm-infected mice if there was no activation of this protein complex
(67). Further, this group demonstrated that inhibition of cathepsin B resulted in IL-1
activation interruption in a dose-dependent manner on cells. While this report showed
the importance of cathepsin B in the activation of host protection against C. neoformans
in vivo, Smith et al. showed that macrophage infection with C. neoformans results in lack
of cathepsin L activation, which is a phagosome maturation late-stage marker. In the
latter study, heat-killed C. neoformans had significant activation of cathepsin L (34).
There is no clear link between vomocytosis and cathepsins. However, these studies
demonstrate that this class of proteins may play a role in this special event, as cathepsin
activity is affected by C. neoformans infection. Moreover, these studies imply a role for
FIG 2 Recruitment of Rab GTPases onto the Cryptococcus-containing phagosome. Immunofluorescence analysis was
conducted at 15 min and 2 h to detect Rab5 (A), Rab11 (B), Rab9 (C), and Rab7 (D) recruitment to phagosomes containing
live C. neoformans on J774 cells. This figure has been adapted from reference 34, and the data were described therein.
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phagosomal pH and other physicochemical factors which influence cathepsin activa-
tion in vomocytosis.
Annexin A2 expression. Annexin A2 is a membrane-bound protein involved in
many processes, including phagocytosis, endocytosis, and exocytosis. Gene expression
for this protein is upregulated in brain endothelial cells during transmigration of C.
neoformans (55). Therefore, Stukes et al. investigated the role of annexin A2 in the
interaction between macrophages and C. neoformans (68). Murine bone marrow-
derived cells (BMDMs) were harvested and grown from wild-type mice and annexin A2
knockout mice. The investigators found that annexin A2-deficient macrophages exhib-
ited lower rates of phagocytosis, a lower frequency of vomocytosis, and higher occur-
rences of lytic exocytosis than did wild-type macrophages. Other notable observations
of infected annexin A2-deficient macrophages included an increase in C. neoformans
capsule size, lower production of reactive oxygen species, and decreased levels of LC3
in phagosomes. These results align with previous findings that free radicals can damage
and reduce the C. neoformans capsule (69). Stukes and coworkers also tested the
significance of annexin A2 during infection, by infecting wild-type and annexin A2
knockout mice with C. neoformans. The A2 knockout mice had lower rates of survival,
suggesting that this protein is important in controlling fungal infections, with vomo-
cytosis potentially protecting macrophages from eventual lysis. These findings high-
lighted the role of annexin A2 in phagocytosis, antifungal defense mechanisms, and
vomocytosis. While the exact underlying mechanisms of this protein’s involvement are
unclear, the authors theorized that during vomocytosis annexin A2 complexes with its
known binding partner, fusogenic protein SNAP-23, promote fusion between the
phagosome and plasma membrane (70). Furthermore, the Ca2 dependence of an-
nexin A2 could be linked to the intracellular calcium changes observed during vomo-
cytosis.
PHYSICOCHEMICAL CHARACTERISTICS OF VOMOCYTOSIS
Phagosomal pH. An important characteristic of phagosomal maturation is its
acidification. Several studies have demonstrated the ability of C. neoformans to affect
the pH of phagosomes as an indication of phagosomal maturation inhibition. The pH
in the phagosomal environment is highly regulated and controlled by vacuolar mem-
brane ATPase activity. This protein is responsible for the acidification of the phago-
somal compartment to a pH as low as 4.5. This H release is balanced by Cl anions (71,
72). Smith and coworkers demonstrated that significant acidification of the phagosome,
which is distinctive of the phagolysosomal stage, occurred only on phagosomes
containing heat-killed or UV-killed C. neoformans (34). Acidification was hindered by the
presence of live C. neoformans in phagosomes of J774 cells and HMDMs. Moreover,
inhibition of the microbicidal environment resulted in intraphagosomal cryptococcal
budding and vomocytic activity of the internalized C. neoformans. These observations
validated an earlier study by Nicola et al. that noted a relationship between the increase
in phagosomal pH and the enhancement of vomocytosis events (73). Succinctly, they
reported an increase in nonlytic exocytosis events when supplementing C. neoformans-
containing macrophages with the weak bases chloroquine and ammonium chloride.
Later, Fu et al. showed that production of urease was connected with increased
phagolysosomal pH (74). Urease is a major virulence factor of C. neoformans upon
interaction with macrophages. This enzyme breaks down urea into ammonia, which, in
turn, increases the phagosomal pH in infected macrophages (75, 76). In the study by Fu
and coworkers, the alkalinization of phagosomes containing C. neoformans was clearly
demonstrated, and this increase in pH resulted in (i) reduced proliferation of urease-
positive C. neoformans compared to a urease-negative strain, (ii) a decrease in phagoly-
sosomal damage, and (iii) an increase in vomocytic events. An interesting finding of this
study was that even coincubating J774 cells with heat-killed C. neoformans resulted in
an increase in phagosomal pH in comparison to latex beads containing phagosomes
(Fig. 3). The discrepancy between the latter report and what was observed in the study
by Smith et al. could be due to the use of different techniques to measure pH. Fu et al.
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attributed the alkalinization of phagosomes containing heat-killed C. neoformans to
heterogenicity in maturation of evaluated phagosomes and secretion of molecules that
could affect the concentration of hydronium ions by heat-killed pathogen. It is note-
worthy that they also observed that the addition of urea promoted an increase in
nonlytic exocytosis events in macrophages infected with C. neoformans. Interestingly,
urea also promoted nonlytic exocytosis events in urease-negative C. neoformans-
infected macrophages. Taken together, these observations emphasize that increased
FIG 3 The presence of urease increases the phagolysosomal pH. BMDMs were infected with Oregon green-labeled
H99, ure1Δ, and ure1Δ::URE1 strains (top), heat-inactivated (HI) H99 (heat inactivated at 50°C for 30 min), heat-killed
(HK) H99 and ure1Δ strains (heat killed at 50°C for 4 h) (middle), and IgG-coated polystyrene beads (bottom), and
phagolysosomal pH was measured by using dual-excitation ratio fluorescence imaging at the indicated time points.
Each dot represents the pH of individual phagolysosomes. The violin plot displays the probability density of data
set with means (middle bar) and standard deviation. This figure has been adapted from reference 74, and the data
were described therein.
Minireview ®
November/December 2019 Volume 10 Issue 6 e02526-19 mbio.asm.org 7
phagosomal pH facilitates but does not cause vomocytosis. Moreover, vomocytosis is
affected by the presence of urea and urease. Additionally, this report noted an increase
in intracellular replication of C. neoformans in acidic vesicles, corroborating previous
findings of C. neoformans growth under acidic conditions (77). In an in vivo infection
model, urease-deficient C. neoformans was less virulent than wild-type C. neoformans,
which reiterates the importance of vomocytosis to C. neoformans dissemination and
infection.
More recently, De Leon-Rodriguez and coworkers studied the role of the C. neofor-
mans capsule in the pH microenvironment of the phagosome (35). They hypothesized
that glucuronic acid residues in the capsular polysaccharide had buffering capacity in
the phagosome. They infected BMDMs with nonencapsulated C. neoformans organisms
that had been previously coated with different amounts of encapsulated C. neoformans
conditioned medium, which resulted in the attachment of soluble polysaccharide to
their surface. More coating on nonencapsulated cells promoted an increase in phago-
somal pH compared to phagosomes infected with encapsulated C. neoformans. With
these findings, they suggested that the presence of glucuronic acid residues in the
capsule of C. neoformans makes the polysaccharide a weak acid capable of modulating
pH in the phagosome. The capsule’s acid-base properties promote fungal cell survival
in the phagosome by the buffering capacity during microbicidal conditions. While
interesting, the characterization of encapsulated C. neoformans conditioned medium is
necessary to elucidate if there are other factors that would be capable of affecting
phagosomal pH.
Phagosome permeabilization. Phagosome permeabilization has been observed in
several studies with C. neoformans-infected macrophages (36, 51, 78, 79). Davis and
coworkers studied lysosomal permeabilization in bone marrow-derived macrophages
infected by C. neoformans via flow cytometry (51). They detected significant phago-
some permeabilization up to 72 h after C. neoformans infection. Conversely, no signif-
icant permeabilization was observed in macrophages infected with heat-killed C.
neoformans. Since the majority of C. neoformans exocytosis occurs between 5 and 14 h
after macrophage uptake (26, 41), they proposed that if permeabilization is needed for
C. neoformans to escape from lysosomal degradation, C. neoformans exocytosis and C.
neoformans-mediated lysosomal damage are chronologically independent mechanisms
(51).
Three years later, a study by De Leon-Rodriguez et al. sought to further unravel the
relationship between phagosomal pH, phagosomal membrane permeabilization (PMP),
lytic exocytosis, and vomocytosis (36). They found that most C. neoformans-infected
J774.16 cells experiencing PMP were positive for apoptotic markers, demonstrating a
relationship between PMP and apoptosis. However, they still observed populations of
live cells experiencing PMP on BMDMs. Nevertheless, their observations demonstrated
that macrophages undergoing apoptosis did not maintain an acidic phagolysosomal
pH. They investigated the role of phospholipase B1, a virulence factor for both C.
neoformans and C. gattii, in the C. neoformans induction of PMP. Macrophages infected
with a C. neoformans Δplb1 mutant had a decrease in PMP compared to those infected
with wild-type and phospholipase B1-complemented strains, suggesting a mechanism
of action for this virulence factor. However, when evaluating if phospholipase B1
deficiency affected phagosomal pH, their data suggested that pH was unchanged.
Induction of PMP with ciprofloxacin, a membrane-permeabilizing agent, enhanced
macrophages to trigger lytic exocytosis in apoptotic BMDMs. On the other hand,
vomocytic events were common in cell populations without PMP (36). Vomocytosis
occurs with a frequency of 10 to 30% in macrophages and can be modulated by
increases in phagosomal pH with ammonium chloride and chloroquine (73). Interest-
ingly, these two compounds not only raise the phagolysosomal pH but also build
osmotic pressure across the phagolysosomal membrane through the proton sponge
effect, thereby affecting its permeability (80, 81). De Leon-Rodriguez and coworkers
showed that chemical induction of PMP in C. neoformans-infected macrophages leads
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to a decrease of vomocytic events to mainly lytic exocytosis, signifying that vomocy-
tosis occurs when there is no PMP. The basis of this inference is that the frequency of
nonlytic exocytosis peaks before 4 h, when most macrophages still have intact phagoly-
sosomal membranes. However, they failed to account for dragotcytosis (82).
Calcium transport. Calcium ions (Ca2) are critical second messengers that regulate
key signaling pathways in eukaryotic cells. In the context of phagocytosis, Ca2
elevations are necessary for efficient ingestion of foreign particles by some phagocytic
receptors and subsequent phagosomal maturation. Ca2 is required for the solubiliza-
tion of the actin meshwork that surrounds nascent phagosomes, for the fusion of
phagosomes with granules containing lytic enzymes, for the assembly and activation of
the superoxide-generating NADPH oxidase complex, and for exocytosis (83–89). Given
the role of Ca2 ions in these related phenomena, some studies have delved into its
role in vomocytosis. For instance, Smith et al. investigated the effect of C. neoformans
on phagosomal and cytosolic calcium levels after infection (34). They observed reduced
levels of Ca2 in phagosomes containing C. neoformans compared to cytosolic levels up
to 120 min after infection (Fig. 4). Interestingly, they found that phagosomes that
contained heat-killed C. neoformans had greater calcium concentrations than cytosolic
Ca2 levels after infection (34). Although they did not study the relationship between
phagosomal Ca2 levels and vomocytic events, this is a good indication of the
relevance calcium may have in this process.
In a later study, Samantaray et al. investigated the relationship between phagosomal
calcium levels and C. neoformans survival and proliferation via the use of the L-type
calcium channel blocker fendiline hydrochloride (90). This drug is thought to trigger
endoplasmic reticulum calcium store release, thus elevating cytosolic Ca2 and its
signaling pathways (91, 92). They found that C. neoformans-containing phagosomes
acidify when macrophages are exposed to the drug. This acidification promoted C.
neoformans death and decreased the proliferation rate. Thus, enhancement of calcium
intracellular signaling pathways promoted phagosomal maturation. The investigators
did not specifically determine phagosomal pH of experimental groups, which makes it
difficult to relate these results with previous discussed studies that demonstrate an
increase in C. neoformans proliferation under acidic phagosomal conditions. Nevertheless,
the studies by Samantaray et al. and Smith et al. make evident that Ca2 influx-dependent
signaling is affected by C. neoformans and that the pathogen’s virulence potential can be
modulated by manipulating Ca2 concentrations.
EFFECT OF IMMUNE STATE ON VOMOCYTOSIS
Viral infection and type I interferon. Cryptococcus neoformans primarily infects
immunocompromised hosts, such as HIV patients. Seoane et al. investigated the effect
FIG 4 Phagosomes containing live C. neoformans do not accumulate calcium, in contrast to phagosomes
containing heat-killed C. neoformans. Fluorescence intensity data from each cryptococcus-containing
phagosome (live C. neoformans H99 or heat-killed H99 [HK H99]) were normalized to a randomly selected
region of cytoplasm within the same cell preloaded with Oregon green BAPTA-1 1 h before infection.
Data displayed are fluorescence intensity relative to that of cytoplasm, sampled every 15 min over the
course of a time-lapse experiment; values are means SEM (n 35 phagosomes) across three biological
repeats. Data are as described previously (34).
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of viral infection on vomocytosis (93). They found that infection with HIV or measles
virus significantly boosts the frequency of vomocytosis in C. neoformans-containing
human monocyte-derived macrophages while leaving phagocytic uptake and intracel-
lular fungal proliferation rates unaffected. Poly(I·C), a potent Toll-like receptor 3 (TLR3)
agonist that induces antiviral responses in macrophages, alone was also shown to
increase vomocytosis rates. These findings suggest that the macrophage response to
viral infection, rather than active viral pathogenicity, is the factor that modulates
vomocytosis. Furthermore, since viral infections are known for inducing expression of
type I interferons (IFNs), such as IFN- and IFN-, these researchers tested how
stimulation with IFN- affects vomocytosis rates. Addition of IFN- to non-virally
infected macrophages was shown to produce an enhancement of vomocytosis fre-
quency comparable to that of the virally infected group. Moreover, pharmacological
inhibition of type I interferon receptors blocked the increase of vomocytosis during viral
infections, confirming the role of type I interferon signaling in modulating this process.
This study shows that vomocytosis likely occurs at a high rate in HIV patients and is
likely linked to pathways involving type I interferon receptors.
Cytokines.Many cytokines have been investigated for their effect on the interaction
between macrophages and C. neoformans. Various studies on Th1 cytokines IFN- (94),
IL-12 (95), and TNF- (96) demonstrated significantly increased fungal control in mouse
models of C. neoformans infection. Additionally, Th17 cytokines IL-17 (97) and IL-23 (98)
are linked to fungal protection in C. neoformans-infected mice. Conversely, Th2 cyto-
kines IL-4 (99) and IL-13 (100) promote fungal disease progression in mice. However,
none of the authors of these studies linked their observations to vomocytosis.
Therefore, Voelz et al. tested the different T helper cell cytokines for their effect on
infected murine J774 cells and primary monocyte-derived human macrophages (49).
Macrophages were stimulated to a Th1 (IFN- and TNF-), Th2 (IL-4 and IL-13), or Th17
(IL-17) state. Interestingly, Th2 cytokines caused higher rates of intracellular C. neofor-
mans proliferation and lower expulsion rates. Th1 and Th17 cytokines, on the other
hand, reduced intracellular proliferation and caused comparably higher expulsion rates.
Voelz et al. theorize that these distinct T helper cytokines modify the phagosome to
result in different C. neoformans fates—intracellular proliferation (Th2) or expulsion
(Th1 and Th17). The Th2 cytokines IL-4 and IL-13 have been linked to increased iron
availability in macrophages (101); these metal ions could play a role in the character-
istics of C. neoformans in the phagosome.
The last observation of vomocytosis rate in macrophages treated with Th2 cytokines
for M2 polarization is in agreement with the aforementioned study by Gilbert et al. (64),
in which higher vomocytosis rates were observed in ERK5-inhibited macrophages,
along with reduction of their M2 polarization markers. ERK5 inhibition in macrophages
led to a modified inflammatory profile that prevented anti-inflammatory polarization
without modifying their response to inflammatory stimuli. They also observed a de-
crease in the presence of actin filament ruffles on macrophages treated with ERK5
inhibitor. Concisely, Gilbert et al. suggested that vomocytosis enhancement by ERK5
inhibition was a result of reduced M2 macrophage polarization and decline in actin
filament ruffle formation (64).
CONCLUSIONS AND FUTURE PERSPECTIVES
Vomocytosis is a fascinating mechanism that allows select pathogens to escape
from phagocyte degradation while keeping the host cell alive. Specifically, the fungal
pathogen C. neoformans has developed this mechanism, which boosts its survival in the
human body. As of today, researchers have identified distinct biological, immunolo-
gical, and physicochemical factors involved in this phagolysosomal escape event.
In terms of biological factors, the protein composition of the phagosome is highly
altered prior to and during the expulsion of C. neoformans (Fig. 5). Early phagosomes
containing live C. neoformans show a lack of Rab5 and Rab11 endosomal markers and
significantly more Rab9 marker at late phagosomal stages than their counterparts
containing heat-killed cells or latex beads. Also, a lack of cathepsin activity is observed
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in C. neoformans-containing phagosomes. These findings implicate the strong inhibi-
tion of phagosome maturation in macrophages that are actively vomocytosing cells.
Other host proteins involved in vomocytosis include the mitogen-activated protein
(MAP) kinase ERK5 and the membrane phospholipid binding protein annexin A2, but
their exact role in this process is unknown. Outside of biological factors within the cells,
the immune state of this host has shown a strong effect on vomocytosis. This is
unsurprising since vomocytosis has been observed in macrophages and the phago-
some is a crucial component of the innate immune system. Specifically, viral infections,
Th1/2/17 cytokine exposure, and macrophage M1/M2 polarization all affect vomocytic
rates. Lastly, vomocytosis has been linked to alterations in the physicochemical factors
in the phagosome. For instance, Ca2 levels in C. neoformans-containing phagosomes
decline, relative to the cytosol, during vomocytosis. Also, the pH in the phagosome (due
to urease activity and capsule acid-base properties) or in the external media influences
the frequency of vomocytosis. These physicochemical factors may also contribute to
rates of PMP, which are linked to decreased vomocytosis rates and increased proba-
bility for lytic exocytosis.
While we have advanced our understanding of this phenomenon, revisiting its
science using fresh technologies and an interdisciplinary approach could prove knowl-
edge rich. For instance, the relationship between macrophage polarization and vomo-
cytosis was explored 10 years ago (49). However, current technological advances could
allow us to understand, in more depth, the complexity of macrophage phenotypes and
their role in disease prevention and progression. Newer, next-generation sequencing
technologies could provide new insights on the transcriptional and epigenetic profile
of the infected host and fungal cells at different times after infection. This information
could facilitate the identification of key signaling pathways in infection and vomocy-
tosis (as well as lytic exocytosis). Moreover, the gene expression profile of pathogens
during this phenomenon could inspire novel strategies to manipulate phagosomal
escape for a variety of purposes, including the design of drugs to combat the infection
or mimic vomocytosis (102). Some physicochemical changes that occur during vomo-
cytosis (intracellular Ca2 concentration, direct phagosomal pH modulation, and PMP)
have been characterized. However, there are still challenges in understanding their
relationships to vomocytosis. Moreover, there are other key phagosomal physicochem-
ical features that have yet to be investigated with respect to vomocytosis (e.g., oxygen
FIG 5 Vomocytosis occurrence is characterized by distinct intracellular, physicochemical, and immunological factors. Rab
GTPase recruitment to phagosomes, which affects phagosomal maturation and cathepsin activity, is relevant for the
occurrence of vomocytosis. Moreover, the manipulation of the ERK5 signaling pathway, annexin A2, phagosomal pH, and
Ca2 fluxes is capable of promoting vomocytosis occurrence. Finally, the immunological state of the individual and
macrophage phenotype can affect vomocytosis. The arrows point out if the presence of each factor promotes or inhibits
vomocytic events.
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ions). New technology to accurately record and report this event could also be
instrumental for new findings on vomocytosis. Most studies on vomocytosis use
time-lapse microscopy as a quantitative and monitoring tool, which is quite labor-
intensive and inaccurate. Engineering new reporter systems to study vomocytosis will
help to elucidate the interplay between biological, physical, and chemical factors that
influence this behavior. Similarly, accurate measurement of vomocytosis-influencing
factors can draw links to the intracellular fate of phagocytosed C. neoformans in
macrophages. This knowledge will potentially help in designing treatments that target
this fungal pathogen. Excitingly, a comprehensive view of vomocytosis can also lead to
the development of biomimetic drugs that evade the innate immune system for
improved therapeutic outcomes in a plethora of diseases.
ACKNOWLEDGMENTS
We acknowledge support from the following sources: NIH grant R01AI139399 (J.S.L.),
NIH grant R35GM125012 (J.S.L.), NIGMS-funded Pharmacology Training Program grant
T32GM099608 (N.P.), and NSF GRFP grant 1650042 (N.P.).
REFERENCES
1. Iwasaki A, Medzhitov R. 2015. Control of adaptive immunity by the
innate immune system. Nat Immunol 16:343–353. https://doi.org/10
.1038/ni.3123.
2. Maderna P, Godson C. 2003. Phagocytosis of apoptotic cells and the
resolution of inflammation. Biochim Biophys Acta 1639:141–151. https://
doi.org/10.1016/j.bbadis.2003.09.004.
3. Gordon S. 2016. Phagocytosis: an immunobiologic process. Immunity
44:463–475. https://doi.org/10.1016/j.immuni.2016.02.026.
4. Henson PM. 2017. Cell removal: efferocytosis. Annu Rev Cell Dev Biol
33:127–144. https://doi.org/10.1146/annurev-cellbio-111315-125315.
5. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macro-
phage activation. Nat Rev Immunol 8:958–969. https://doi.org/10.1038/
nri2448.
6. Erwig LP, Gow N. 2016. Interactions of fungal pathogens with phago-
cytes. Nat Rev Microbiol 14:163–176. https://doi.org/10.1038/nrmicro
.2015.21.
7. Doshi N, Mitragotri S. 2010. Macrophages recognize size and shape of
their targets. PLoS One 5:e10051-6. https://doi.org/10.1371/journal
.pone.0010051.
8. Walkey CD, Olsen JB, Guo H, Emili A, Chan W. 2012. Nanoparticle size
and surface chemistry determine serum protein adsorption and mac-
rophage uptake. J Am Chem Soc 134:2139–2147. https://doi.org/10
.1021/ja2084338.
9. Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig
F, Castranova V, Thompson M. 2009. Understanding biophysicochemi-
cal interactions at the nano-bio interface. Nat Mater 8:543–557. https://
doi.org/10.1038/nmat2442.
10. Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H. 2015. Nano-
particle uptake: the phagocyte problem. Nano Today 10:487–510.
https://doi.org/10.1016/j.nantod.2015.06.006.
11. Lim JJ, Grinstein S, Roth Z. 2017. Diversity and versatility of phagocytosis:
roles in innate immunity, tissue remodeling, and homeostasis. Front Cell
Infect Microbiol 7:191. https://doi.org/10.3389/fcimb.2017.00191.
12. May RC, Stone NRH, Wiesner DL, Bicanic T, Nielsen K. 2016. Cryptococcus:
from environmental saprophyte to global pathogen. Nat Rev Microbiol
14:106–117. https://doi.org/10.1038/nrmicro.2015.6.
13. Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM,
Denning DW, Loyse A, Boulware DR. 2017. Global burden of disease of
HIV-associated cryptococcal meningitis: an updated analysis. Lancet
Infect Dis 17:873–881. https://doi.org/10.1016/S1473-3099(17)30243-8.
14. Levitz SM. 2001. Does amoeboid reasoning explain the evolution and
maintenance of virulence factors in Cryptococcus neoformans? Proc
Natl Acad Sci U S A 98:14760–14762. https://doi.org/10.1073/pnas
.261612398.
15. Watkins RA, Andrews A, Wynn C, Barisch C, King JS, Johnston SA. 2018.
Cryptococcus neoformans escape from dictyostelium amoeba by both
WASH-mediated constitutive exocytosis and vomocytosis. Front Cell
Infect Microbiol 8:108. https://doi.org/10.3389/fcimb.2018.00108.
16. Santiago-Tirado FH, Onken MD, Cooper JA, Klein RS, Doering TL. 2017.
Trojan horse transit contributes to blood-brain barrier crossing of a
eukaryotic pathogen. mBio 8:e02183-16 . https://doi.org/10.1128/mBio
.02183-16.
17. Casem ML. 2016. Case studies in cell biology. Academic Press, Cam-
bridge, MA.
18. Murray RZ, Stow JL. 2014. Cytokine secretion in macrophages: SNAREs,
Rabs, and membrane trafficking. Front Immunol 5:1–9.
19. Haka AS, Barbosa-Lorenzi VC, Lee HJ, Falcone DJ, Hudis CA, Dannen-
berg AJ, Maxfield FR. 2016. Exocytosis of macrophage lysosomes leads
to digestion of apoptotic adipocytes and foam cell formation. J Lipid
Res 57:980–992. https://doi.org/10.1194/jlr.M064089.
20. Hibbs JB. 1974. Heterocytolysis by macrophages activated by bacillus
Calmette-Guérin: lysosome exocytosis into tumor cells. Science 184:
468–471. https://doi.org/10.1126/science.184.4135.468.
21. Singh RK, Barbosa-Lorenzi VC, Lund FW, Grosheva I, Maxfield FR, Haka
AS. 2016. Degradation of aggregated LDL occurs in complex extracel-
lular sub-compartments of the lysosomal synapse. J Cell Sci 129:
1072–1082. https://doi.org/10.1242/jcs.181743.
22. Di A, Nelson DJ, Bindokas V, Brown ME, Libunao F, Palfrey HC. 2003.
Dynamin regulates focal exocytosis in phagocytosing macrophages.
Mol Biol Cell 14:2016–2028. https://doi.org/10.1091/mbc.e02-09-0626.
23. Han C, Chen T, Yang M, Li N, Liu H, Cao X. 2009. Human SCAMP5, a
novel secretory carrier membrane protein, facilitates calcium-triggered
cytokine secretion by interaction with SNARE machinery. J Immunol
182:2986–2996. https://doi.org/10.4049/jimmunol.0802002.
24. Bielska E, May RC. 2015. What makes Cryptococcus gattii a pathogen?
FEMS Yeast Res 16:1–12.
25. Bain JM, Lewis LE, Okai B, Quinn J, Gow NAR, Erwig LP. 2012. Non-lytic
expulsion/exocytosis of Candida albicans from macrophages. Fungal
Genet Biol 49:677–678. https://doi.org/10.1016/j.fgb.2012.01.008.
26. Alvarez M, Casadevall A. 2006. Phagosome extrusion and host-cell
survival after Cryptococcus neoformans phagocytosis by macrophages.
Curr Biol 16:2161–2165. https://doi.org/10.1016/j.cub.2006.09.061.
27. Evans RJ, Li Z, Hughes WS, Djordjevic JT, Nielsen K, May RC. 2015.
Cryptococcal phospholipase B1 is required for intracellular proliferation
and control of titan cell morphology during macrophage infection.
Infect Immun 83:1296–1304. https://doi.org/10.1128/IAI.03104-14.
28. Erb-Downward JR, Noggle RM, Williamson PR, Huffnagle GB. 2008.
The role of laccase in prostaglandin production by Cryptococcus
neoformans. Mol Microbiol 68:1428–1437. https://doi.org/10.1111/j
.1365-2958.2008.06245.x.
29. Qiu Y, Davis MJ, Dayrit JK, Hadd Z, Meister DL, Osterholzer JJ, William-
son PR, Olszewski MA. 2012. Immune modulation mediated by crypto-
coccal laccase promotes pulmonary growth and brain dissemination of
virulent Cryptococcus neoformans in mice. PLoS One 7:e47853. https://
doi.org/10.1371/journal.pone.0047853.
30. O’Meara TR, Alspaugh JA. 2012. The Cryptococcus neoformans capsule:
a sword and a shield. Clin Microbiol Rev 25:387–408. https://doi.org/
10.1128/CMR.00001-12.
Minireview ®
November/December 2019 Volume 10 Issue 6 e02526-19 mbio.asm.org 12
31. Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chrétien F,
Heitman JH, Dromer F, Nielsen KN. 2010. Cryptococcal cell morphology
affects host cell interactions and pathogenicity. PLoS Pathog 6 https://
doi.org/10.1371/annotation/1b59fd9e-9ac9-4ea8-a083-14c413c80b03.
32. Artavanis-Tsakonas K, Love JC, Ploegh HL, Vyas JM. 2006. Recruitment
of CD63 to Cryptococcus neoformans phagosomes requires acidifica-
tion. Proc Natl Acad Sci U S A 103:15945–15950. https://doi.org/10
.1073/pnas.0607528103.
33. Levitz SM, Nong SH, Seetoo KF, Harrison TS, Speizer RA, Simons ER.
1999. Cryptococcus neoformans resides in an acidic phagolysosome of
human macrophages. Infect Immun 67:885–890.
34. Smith LM, Dixon EF, May RC. 2015. The fungal pathogen Cryptococcus
neoformans manipulates macrophage phagosome maturation. Cell Mi-
crobiol 17:702–713. https://doi.org/10.1111/cmi.12394.
35. De Leon-Rodriguez CM, Fu MS, Çorbalis OM, Cordero RJB, Casavedal A.
2018. The capsule of Cryptococcus neoformans modulates phagosomal
pH through it acid-base properties. mSphere 3:e00437-18. https://doi
.org/10.1128/mSphere.00437-18.
36. De Leon-Rodriguez CM, Rossi DCP, Fu MS, Dragotakes Q, Coelho C,
Guerrero Ros I, Caballero B, Nolan SJ, Casadevall A. 2018. The outcome
of the Cryptococcus neoformans-macrophage interaction depends on
phagolysosomal membrane integrity. J Immunol 201:583–603. https://
doi.org/10.4049/jimmunol.1700958.
37. Burch KH, Fine G, Quinn EL, Eisses JF. 1975. Cryptococcus neoformans
as a cause of lytic bone lesions. JAMA 231:1057–1059. https://doi.org/
10.1001/jama.1975.03240220037017.
38. Hommel B, Mukaremera L, Cordero RJB, Coelho C, Desjardins CA,
Sturny-Leclère A, Janbon G, Perfect JR, Fraser JA, Casadevall A, Cuomo
CA, Dromer F, Nielsen K, Alanio A. 2018. Titan cells formation in
Cryptococcus neoformans is finely tuned by environmental conditions
and modulated by positive and negative genetic regulators. PLoS
Pathog 14:e1006982. https://doi.org/10.1371/journal.ppat.1006982.
39. Zaragoza O, Rocío GR, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela
JL, Casadevall A. 2010. Fungal cell gigantism during mammalian infection.
PLoS Pathog 6:e1000945. https://doi.org/10.1371/annotation/0675044c
-d80f-456f-bb63-4f85fb1d0c33.
40. Ben-Abdallah M, Sturny-Leclère A, Avé P, Louise A, Moyrand F, Weih F,
Janbon G, Mémet S. 2012. Fungal-induced cell cycle impairment, chromo-
some instability and apoptosis via differential activation of NF-B. PLoS
Pathog 8:e1002555. https://doi.org/10.1371/journal.ppat.1002555.
41. Ma H, Croudace JE, Lammas DA, May RC. 2006. Expulsion of live
pathogenic yeast by macrophages. Curr Biol 16:2156–2160. https://doi
.org/10.1016/j.cub.2006.09.032.
42. Hybiske K, Stephens R. 2007. Mechanisms of host cell exit by the
intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A 104:
11430–11435. https://doi.org/10.1073/pnas.0703218104.
43. Chu H, Lee JH, Han SH, Kim SY, Cho NH, Kim IS, Choi MS. 2006.
Exploitation of the endocytic pathway by Orientia tsutsugamushi in
nonprofessional phagocytes. Infect Immun 74:4246–4253. https://doi
.org/10.1128/IAI.01620-05.
44. Leopold Wager CM, Hole CR, Wozniak KL, Wormley FL. 2016. Crypto-
coccus and phagocytes: complex interactions that influence disease
outcome. Front Microbiol 7:1–16.
45. Wozniak KL, Olszewski MA, Wormley FL. 2015. Molecules at the interface of
Cryptococcus and the host that determine disease susceptibility. Fungal
Genet Biol 78:87–92. https://doi.org/10.1016/j.fgb.2014.10.013.
46. Johnston SA, May RC. 2010. The human fungal pathogen Cryptococcus
neoformans escapes macrophages by a phagosome emptying mecha-
nism that is inhibited by arp2/3 complex-mediated actin polymerisation.
PLoS Pathog 6:e1001041. https://doi.org/10.1371/journal.ppat.1001041.
47. Alvarez M, Saylor C, Casadevall A. 2008. Antibody action after phagocytosis
promotes Cryptococcus neoformans and Cryptococcus gattii macrophage
exocytosis with biofilm-like microcolony formation. Cell Microbiol 10:
1622–1633. https://doi.org/10.1111/j.1462-5822.2008.01152.x.
48. Dragotakes Q, Fu MS, Casadevall A. 2019. Dragotcytosis: elucidation of the
mechanism for Cryptococcus neoformans macrophage-to-macrophage
transfer. J Immunol 203:1801118.
49. Voelz K, Lammas DA, May RC. 2009. Cytokine signaling regulates the
outcome of intracellular macrophage parasitism by Cryptococcus neofor-
mans. Infect Immun 77:3450–3457. https://doi.org/10.1128/IAI.00297-09.
50. Diamond RD, Bennett JE. 1973. Growth of Cryptococcus neoformans
within human macrophages in vitro. Infect Immun 7:231–236.
51. Davis MJ, Eastman AJ, Qiu Y, Gregorka B, Kozel TR, Osterholzer JJ, Curtis JL,
Swanson JA, Olszewski MA. 2015. Cryptococcus neoformans-inducedmac-
rophage lysosome damage crucially contributes to fungal virulence. J
Immunol 194:2219–2231. https://doi.org/10.4049/jimmunol.1402376.
52. Liu T, Perlin DS, Xue C. 2012. Molecular mechanisms of cryptococcal
meningitis. Virulence 3:173–181. https://doi.org/10.4161/viru.18685.
53. Charlier C, Chrétien F, Baudrimont M, Mordelet E, Lortholary O, Dromer
F. 2005. Capsule structure changes associated with Cryptococcus neo-
formans crossing of the blood-brain barrier. Am J Pathol 166:421–432.
https://doi.org/10.1016/S0002-9440(10)62265-1.
54. Chang YC, Wang Z, Flax LA, Xu D, Esko JD, Nizet V, Baron MJ. 2011.
Glycosaminoglycan binding facilitates entry of a bacterial pathogen
into central nervous systems. PLoS Pathog 7:e1002082. https://doi.org/
10.1371/journal.ppat.1002082.
55. Vu K, Eigenheer RA, Phinney BS, Gelli A. 2013. Cryptococcus neofor-
mans promotes its transmigration into the central nervous system by
inducing molecular and cellular changes in brain endothelial cells.
Infect Immun 81:3139–3147. https://doi.org/10.1128/IAI.00554-13.
56. Vu K, Weksler B, Romero I, Couraud PO, Gelli A. 2009. Immortalized
human brain endothelial cell line HCMEC/D3 as a model of the blood-
brain barrier facilitates in vitro studies of central nervous system infec-
tion by Cryptococcus neoformans. Eukaryot Cell 8:1803–1807. https://
doi.org/10.1128/EC.00240-09.
57. Chen SHM, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, Chang Y,
Kim KS, Suzuki K, Jong AY. 2003. Cryptococcus neoformans induces
alterations in the cytoskeleton of human brain microvascular endothe-
lial cells. J Med Microbiol 52:961–970. https://doi.org/10.1099/jmm.0
.05230-0.
58. Aaron PA, Jamklang M, Uhrig JP, Gelli A. 2018. The human blood-brain
barrier internalizes Cryptococcus neoformans via the EphA2-tyrosine
kinase receptor. Cell Microbiol 20:139–144.
59. Guerra CR, Seabra SH, De Souza W, Rozental S. 2014. Cryptococcus
neoformans is internalized by receptor-mediated or “triggered” phago-
cytosis, dependent on actin recruitment. PLoS One 9:e89250. https://
doi.org/10.1371/journal.pone.0089250.
60. Kjos I, Vestre K, Guadagno NA, Borg Distefano M, Progida C. 2018. Rab
and Arf proteins at the crossroad between membrane transport and
cytoskeleton dynamics. Biochim Biophys Acta Mol Cell Res 1865:
1397–1409. https://doi.org/10.1016/j.bbamcr.2018.07.009.
61. Pauwels AM, Trost M, Beyaert R, Hoffmann E. 2017. Patterns, receptors,
and signals: regulation of phagosome maturation. Trends Immunol
38:407–422. https://doi.org/10.1016/j.it.2017.03.006.
62. Drew BA, Burow ME, Beckman BS. 2012. MEK5/ERK5 pathway: the first
fifteen years. Biochim Biophys Acta 1825:37–48. https://doi.org/10
.1016/j.bbcan.2011.10.002.
63. Wang X, Pesakhov S, Harrison JS, Kafka M, Danilenko M, Studzinski GP.
2015. The MAPK ERK5, but not ERK1/2, inhibits the progression of
monocytic phenotype to the functioning macrophage. Exp Cell Res
330:199–211. https://doi.org/10.1016/j.yexcr.2014.10.003.
64. Gilbert AS, Seoane PI, Sephton-Clark P, Bojarczuk A, Hotham R, Giuri-
sato E, Sarhan AR, Hillen A, Vande VG, Gray NS, Alessi DR, Cunningham
DL, Tournier C, Johnston SA. 2017. Vomocytosis of live pathogens from
macrophages is regulated by the atypical MAP kinase ERK5. Sci Adv
3:1–8.
65. Heo KS, Cushman HJ, Akaike M, Woo CH, Wang X, Qiu X, Fujiwara K,
Abe JI. 2014. ERK5 activation in macrophages promotes efferocytosis
and inhibits atherosclerosis. Circulation 130:180–191. https://doi.org/
10.1161/CIRCULATIONAHA.113.005991.
66. Franchi L, Muñoz-Planillo R, Núñez G. 2012. Sensing and reacting to
microbes through the inflammasomes. Nat Immunol 13:325–332.
https://doi.org/10.1038/ni.2231.
67. Lei G, Chen M, Li H, Niu J-L, Wu S, Mao L, Lu A, Wang H, Chen W, Xu B,
Leng Q, Xu C, Yang G, An L, Zhu L-P, Meng G. 2013. Biofilm from a
clinical strain of Cryptococcus neoformans activates the NLRP3 inflam-
masome. Cell Res 23:965–968. https://doi.org/10.1038/cr.2013.49.
68. Stukes S, Coelho C, Rivera J, Jedlicka AE, Hajjar KA, Casadevall A. 2016.
The membrane phospholipid binding protein annexin A2 promotes
phagocytosis and nonlytic exocytosis of Cryptococcus neoformans and
impacts survival in fungal infection. J Immunol 197:1252–1261. https://
doi.org/10.4049/jimmunol.1501855.
69. Bryan RA, Zaragoza O, Zhang T, Ortiz G, Casadevall A, Dadachova E.
2005. Radiological studies reveal radial differences in the architecture
of the polysaccharide capsule of Cryptococcus neoformans. Eukaryot
Cell 4:465–475. https://doi.org/10.1128/EC.4.2.465-475.2005.
70. Wang P, Chintagari NR, Gou D, Su L, Liu L. 2007. Physical and functional
Minireview ®
November/December 2019 Volume 10 Issue 6 e02526-19 mbio.asm.org 13
interactions of SNAP-23 with annexin A2. Am J Respir Cell Mol Biol
37:467–476. https://doi.org/10.1165/rcmb.2006-0447OC.
71. Yates RM, Hermetter A, Russell G. 2005. The kinetics of phagosome
maturation as a function of phagosome/lysosome fusion and acquisi-
tion of hydrolytic activity. Traffic 6:413–420. https://doi.org/10.1111/j
.1600-0854.2005.00284.x.
72. Russell DG, Vanderven B, Glennie S, Mwandumba H, Heyderman R.
2009. The macrophage marches on its phagosome: dynamic assays of
phagosome function. Nat Rev Immunol 9:594–600. https://doi.org/10
.1038/nri2591.
73. Nicola AM, Robertson EJ, Albuquerque P, Derengowski LS, Casadevall
A. 2011. Nonlytic exocytosis of Cryptococcus neoformans from macro-
phages occurs in vivo and is influenced by phagosomal pH. mBio
2:e00167-11. https://doi.org/10.1128/mBio.00167-11.
74. Fu MS, Coelho C, De Leon-Rodriguez CM, Rossi DCP, Camacho E,
Jung EH, Kulkarni M, Casadevall A. 2018. Cryptococcus neoformans
urease affects the outcome of intracellular pathogenesis by modu-
lating phagolysosomal pH. PLoS Pathog 14:e1007144. https://doi
.org/10.1371/journal.ppat.1007144.
75. Denham S, Brown J. 2018. Mechanisms of pulmonary escape and
dissemination by Cryptococcus neoformans. J Fungi 4:25. https://doi
.org/10.3390/jof4010025.
76. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR. 2000. Urease as
a virulence factor in experimental cryptococcosis. Infect Immun 68:
443–448. https://doi.org/10.1128/iai.68.2.443-448.2000.
77. Yoshida S, Ohkusu M, Hata K, Yarita K, Fujii T, Takeo K. 2001. Early
death at medium acidification and survival after low pH adaptation
in Cryptotoccus neoformans. Mycoscience 42:535–541. https://doi
.org/10.1007/BF02460951.
78. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus
neoformans is a facultative intracellular pathogen in murine pulmonary
infection. Infect Immun 68:4225–4237. https://doi.org/10.1128/iai.68.7
.4225-4237.2000.
79. Tucker SC, Casadevall A. 2002. Replication of Cryptococcus neoformans
in macrophages is accompanied by phagosomal permeabilization and
accumulation of vesicles containing polysaccharide in the cytoplasm.
Proc Natl Acad Sci U S A 99:3165–3170. https://doi.org/10.1073/pnas
.052702799.
80. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D,
Ojcius DM, Jäättelä M, Kroemer G. 2003. Lysosomal membrane permea-
bilization induces cell death in a mitochondrion-dependent fashion. J
Exp Med 197:1323–1334. https://doi.org/10.1084/jem.20021952.
81. Circu M, Cardelli J, Barr MP, O’Byrne K, Mills G, El-Osta H. 2017. Mod-
ulating lysosomal function through lysosome membrane permeabili-
zation or autophagy suppression restores sensitivity to cisplatin in
refractory non-small-cell lung cancer cells. PLoS One 12:e0184922.
https://doi.org/10.1371/journal.pone.0184922.
82. Stukes SA, Cohen HW, Casadevall A. 2014. Temporal kinetics and
quantitative analysis of Cryptococcus neoformans nonlytic exocytosis.
Infect Immun 82:2059–2067. https://doi.org/10.1128/IAI.01503-14.
83. Kusner DJ, Barton JA. 2001. ATP stimulates human macrophages to kill
intracellular virulent Mycobacterium tuberculosis via calcium-
dependent phagosome-lysosome fusion. J Immunol 167:3308–3315.
https://doi.org/10.4049/jimmunol.167.6.3308.
84. Nunes P, Demaurex N. 2010. The role of calcium signaling in phago-
cytosis. J Leukoc Biol 88:57–68. https://doi.org/10.1189/jlb.0110028.
85. Kruskal BA, Maxfield FR. 1987. Cytosolic free calcium increases before
and oscillates during frustrated phagocytosis in macrophages. J Cell
Biol 105:2685–2693. https://doi.org/10.1083/jcb.105.6.2685.
86. Myers JT, Swanson JA. 2002. Calcium spikes in activated macrophages
during Fc receptor-mediated phagocytosis. J Leukoc Biol 72:677–684.
87. Lévêque M, Penna A, Le Trionnaire S, Belleguic C, Desrues B, Brinchault
G, Jouneau S, Lagadic-Gossmann D, Martin-Chouly C. 2018. Phagocy-
tosis depends on TRPV2-mediated calcium influx and requires TRPV2 in
lipids rafts: alteration in macrophages from patients with cystic fibrosis.
Sci Rep 8:4310. https://doi.org/10.1038/s41598-018-22558-5.
88. Vashi N, Andrabi SBA, Ghanwat S, Suar M, Kumar D. 2017. Ca2-
dependent focal exocytosis of Golgi-derived vesicles helps phagocytic
uptake in macrophages. J Biol Chem 292:5144–5165. https://doi.org/
10.1074/jbc.M116.743047.
89. Swisher JFA, Burton N, Bacot SM, Vogel SN, Feldman GM. 2010. Annexin
A2 tetramer activates human and murine macrophages through TLR4.
Blood 115:549–558. https://doi.org/10.1182/blood-2009-06-226944.
90. Samantaray S, Correia JN, Garelnabi M, Voelz K, May RC, Hall RA. 2016.
Novel cell-based in vitro screen to identify small-molecule inhibitors
against intracellular replication of Cryptococcus neoformans in macro-
phages. Int J Antimicrob Agents 48:69–77. https://doi.org/10.1016/j
.ijantimicag.2016.04.018.
91. Huang CC, Huang CJ, Cheng JS, Liu SI, Chen IS, Tsai JY, Chou CT, Tseng PL,
Jan CR. 2015. Fendiline-evoked [Ca2]i rises in human oral cancer cells.
Hum Exp Toxicol 28:41–48. https://doi.org/10.1177/0960327108097436.
92. Cheng JS, Wang JL, Lo YK, Chou KJ, Lee KC, Liu CP, Chang HT, Jan CR.
2001. Effects of the antianginal drug fendiline on Ca2 movement in
hepatoma cells. Hum Exp Toxicol 20:359–364. https://doi.org/10.1191/
096032701680350523.
93. Seoane PI, Taylor-Smith LM, Stirling D, Bell LCK, Noursadeghi M, Bailey
D, May RC. 2019. Viral infection enhances vomocytosis of intracellular
fungi via type I interferons. bioRxiv 2019:512293.
94. Wormley FL, Perfect JR, Steele C, Cox GM. 2007. Protection against
cryptococcosis by using a murine gamma interferon-producing Cryp-
tococcus neoformans strain. Infect Immun 75:1453–1462. https://doi
.org/10.1128/IAI.00274-06.
95. Hoag KA, Lipscomb MF, Izzo AA, Street NE. 1997. IL-12 and IFN- are
required for initiating the protective Th1 response to pulmonary cryp-
tococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 17:
733–739. https://doi.org/10.1165/ajrcmb.17.6.2879.
96. Milam JE, Herring-Palmer AC, Pandrangi R, McDonald RA, Huffnagle GB,
Toews GB. 2007. Modulation of the pulmonary type 2 T-cell response to
Cryptococcus neoformans by intratracheal delivery of a tumor necrosis
factor alpha-expressing adenoviral vector. Infect Immun 75:4951–4958.
https://doi.org/10.1128/IAI.00176-07.
97. Murdock BJ, Huffnagle GB, Olszewski MA, Osterholzer JJ. 2014.
Interleukin-17A enhances host defense against cryptococcal lung in-
fection through effects mediated by leukocyte recruitment, activation,
and gamma interferon production. Infect Immun 82:937–948. https://
doi.org/10.1128/IAI.01477-13.
98. Kleinschek MA, Muller U, Brodie SJ, Stenzel W, Kohler G, Blumenschein
WM, Straubinger RK, McClanahan T, Kastelein RA, Alber G. 2006. IL-23
enhances the inflammatory cell response in Cryptococcus neoformans
infection and induces a cytokine pattern distinct from IL-12. J Immunol
176:1098–1106. https://doi.org/10.4049/jimmunol.176.2.1098.
99. Blackstock R, Murphy JW. 2004. Role of interleukin-4 in resistance to
Cryptococcus neoformans infection. Am J Respir Cell Mol Biol 30:
109–117. https://doi.org/10.1165/rcmb.2003-0156OC.
100. Müller U, Stenzel W, Köhler G, Werner C, Polte T, Hansen G, Schütze N,
Straubinger RK, Blessing M, McKenzie ANJ, Brombacher F, Alber G.
2007. IL-13 induces disease-promoting type 2 cytokines, alternatively
activated macrophages and allergic inflammation during pulmonary
infection of mice with Cryptococcus neoformans. J Immunol 179:
5367–5377. https://doi.org/10.4049/jimmunol.179.8.5367.
101. Weiss G, Bogdan C, Hentze MW. 1997. Pathways for the regulation of
macrophage iron metabolism by the anti-inflammatory cytokines IL-4
and IL-13. J Immunol 158:420–425.
102. Lewis JS, Keselowsky BG. 2014. Immunomimetic materials, p 357–369.
In Brennan AB, Kirschner CM (ed), Bio-inspired materials for biomedical
engineering. Wiley, Hoboken, NJ.
Minireview ®
November/December 2019 Volume 10 Issue 6 e02526-19 mbio.asm.org 14
